Rongfang Shi

Rongfang Shi

Auto-generated profile, based on publicly available information

Rongfang Shi

Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
YZYafang Zhu
Yafang Zhu
XZXia Zhang
Xia Zhang
SYShoujiang You
Shoujiang You
XCXiaowei Cao
Xiaowei Cao
XWXuan Wang
Xuan Wang
RSRongfang Shi
Rongfang Shi

16 August 2023 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
QLQiuwan Liu
Qiuwan Liu
CMCheng-Jie Mao
Cheng-Jie Mao
ZLZhao-Hui Lu
Zhao-Hui Lu
RSRong-Fang Shi
Rong-Fang Shi
YZYingchun Zhang
Yingchun Zhang
CLChun-Feng Liu
Chun-Feng Liu
Background: Sarcopenia is commonly seen in the older adults and increases in incidence with age, also in Parkinson’s disease (PD). Although research has indicated that the development of sarcopenia in patients with PD may be related to both motor symptoms and non-motor symptoms (NMS), the precise relationship between the two conditions remains unclear. Therefore, we aimed to investigate the incidence of sarcopenia in patients with PD and its association with NMS. Methods: The study included 123 patients with PD and 38 age- and sex-matched healthy controls (HC). All participants were evaluated for sarcopenia using the 2019 Asian Sarcopenia Diagnostic Criteria, and patients with PD underwent standard assessments of motor symptoms and NMS. Multiple logistic regression and receiver operating characteristic (ROC) curve analyses were used to examine the association between sarcopenia and NMS in patients with PD. Results: The incidence of sarcopenia was significantly higher in patients with PD than in HC (26.8% vs. 10.4%, p = 0.046). Multiple logistic regression analysis revealed that poorer sleep quality (odds ratio [OR]: 1.245; 95% confidence interval [CI]: 1.011–1.533; p = 0.040) and fatigue (OR: 1.085, 95% CI: 1.006–1.170, p = 0.034) were independently associated with sarcopenia. ROC analysis indicated that the optimal cut-off value for Pittsburgh Sleep Quality Index (PSQI) scores was 10, with 72.7% sensitivity and 74.4% specificity (area under the curve [AUC] = 0.776, 95% CI: 0.683–0.868, p < 0.001). The optimal cut-off value for Fatigue Severity Scale (FSS) scores was 39, with 87% sensitivity and 50% specificity (AUC = 0.725, 95% CI: 0.629 –0.820, p < 0.001). Joint use of FSS and PSQI scores increased the predictive value for sarcopenia(AUC = 0.804, 95% CI: 0.724–0.885, p < 0.001). Conclusion: Patients with PD are more susceptible to sarcopenia than healthy older adults, and fatigue and poorer sleep are positively associated with sarcopenia. Further longitudinal studies are needed to clarify the causal relationships.

1 July 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
YWYan Wu
Yan Wu
XWXuechun Wu
Xuechun Wu
HPHong Pan
Hong Pan
YZYafang Zhu
Yafang Zhu
YQYan Qin
Yan Qin
XZXia Zhang
Xia Zhang